Based on these results, it was hypothesized that a reduced proportion of total T cells mirrored by increased CD8+, TIA‐1+ T cells in the tumor and/or lesion might correlate with a positive response to IL‐12 therapy. The gene discussed is CD8A; the disease is neoplasm.